AU2003217916A8 - Stable formulations of angiotensin converting enzyme (ace) inhibitors - Google Patents

Stable formulations of angiotensin converting enzyme (ace) inhibitors

Info

Publication number: AU2003217916A8
Authority: AU; Australia
Prior art keywords: ace; inhibitors; converting enzyme; angiotensin converting; stable formulations
Prior art date: 2002-03-08
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003217916A

Other versions

AU2003217916A1 (en

Inventor

Christopher L Pelloni

Robert Gwozdz

Scott Stofik

John C James

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Teva Pharmaceuticals USA Inc

Original Assignee

Teva Pharmaceuticals USA Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-03-08

Filing date

2003-03-06

Publication date

2003-09-22

2003-03-06 Application filed by Teva Pharmaceuticals USA Inc filed Critical Teva Pharmaceuticals USA Inc

2003-09-22 Publication of AU2003217916A1 publication Critical patent/AU2003217916A1/en

2003-09-22 Publication of AU2003217916A8 publication Critical patent/AU2003217916A8/en

Status Abandoned legal-status Critical Current

Links

UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 title 1
102000004270 Peptidyl-Dipeptidase A Human genes 0.000 title 1
108090000882 Peptidyl-Dipeptidase A Proteins 0.000 title 1
238000009472 formulation Methods 0.000 title 1
239000003112 inhibitor Substances 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Inorganic Chemistry (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

AU2003217916A 2002-03-08 2003-03-06 Stable formulations of angiotensin converting enzyme (ace) inhibitors Abandoned AU2003217916A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US9384902A	2002-03-08	2002-03-08
US10/093,849		2002-03-08
PCT/US2003/006606 WO2003075842A2 (en)	2002-03-08	2003-03-06	Stable formulations of angiotensin converting enzyme (ace) inhibitors

Publications (2)

Publication Number	Publication Date
AU2003217916A1 AU2003217916A1 (en)	2003-09-22
AU2003217916A8 true AU2003217916A8 (en)	2003-09-22

Family

ID=27804229

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003217916A Abandoned AU2003217916A1 (en)	2002-03-08	2003-03-06	Stable formulations of angiotensin converting enzyme (ace) inhibitors

Country Status (2)

Country	Link
AU (1)	AU2003217916A1 (en)
WO (1)	WO2003075842A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2394660A (en) *	2003-12-17	2004-05-05	Niche Generics Ltd	Stabilisation of pharmaceutical compositions comprising ACE inhibitor by absence of acidic excipients having large specific surface area, eg silicon dioxide
US20080234353A1 (en) *	2004-03-24	2008-09-25	Reynir Eyjolfsson	Formulations of Ramipril
US20070172524A1 (en) *	2004-03-29	2007-07-26	Krka, Tovarna Zdravil, D.D., Novo Mesto	Process for preparing a solid pharmaceutical composition
SI21800A (en)	2004-05-14	2005-12-31	Krka, Tovarna Zdravil, D.D., Novo Mesto	New procedure of synthesis of perindopril
RU2429878C2 (en)	2005-11-17	2011-09-27	Силверстоун Фарма Ист	Stable formulation of amorphous peridontopril salts, method for preparation thereof, particularly commercial production thereof, and application thereof in therapy of hypertension
PT1864677E (en) *	2006-06-02	2008-03-13	Teva Pharma	Stable formulation comprising a moisture sensitive drug and manufacturing procedure thereof
JP2009538905A (en) *	2006-06-02	2009-11-12	テバファーマシューティカルインダストリーズリミティド	Stable formulation comprising moisture sensitive drug and method for producing the same
US20100035955A1 (en) *	2006-06-30	2010-02-11	Panagiotis Keramidas	Stabilised Composition Comprising ACE Inhibitors
WO2008008057A1 (en) *	2006-07-10	2008-01-17	Teva Pharmaceutical Industries Ltd.	Stable formulation comprising a combination of a moisture sensitive drug and a second drug and manufacturing procedure thereof
WO2009053994A1 (en) *	2007-10-26	2009-04-30	Matrix Laboratories Limited	Process for preparing pure amorphous quinapril hydrochloride
SI2793866T1 (en)	2011-12-21	2016-01-29	Novartis Tiergesundheit Ag	New combination
WO2013135852A1 (en)	2012-03-15	2013-09-19	Boehringer Ingelheim Vetmedica Gmbh	Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9600120D0 (en) *	1996-01-15	1996-01-15	Astra Ab	Novel medical use

2003
- 2003-03-06 WO PCT/US2003/006606 patent/WO2003075842A2/en not_active Ceased
- 2003-03-06 AU AU2003217916A patent/AU2003217916A1/en not_active Abandoned

Also Published As

Publication number	Publication date
AU2003217916A1 (en)	2003-09-22
WO2003075842A2 (en)	2003-09-18
WO2003075842A3 (en)	2004-01-08

Similar Documents

Publication	Publication Date	Title
AU2003282920A8 (en)	2004-05-04	Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme (tace)
EP1534290A4 (en)	2006-11-29	Novel inhibitors of kinases
EP1549316A4 (en)	2008-04-09	INHIBITORS OF TFGbeta
PL377825A1 (en)	2006-02-20	Diaminotriazoles useful as inhibitors of protein kinases
AU2003220401A8 (en)	2003-10-08	Uracil derivatives as inhibitors of tnf-alpha converting enzyme (tace) and matrix metalloproteinases
AU2003217105A1 (en)	2003-09-16	Novel of cytokine inhibitors
AU2003211093A8 (en)	2003-09-09	Inhibitors of rgs proteins
IL165475A0 (en)	2006-01-15	Nitrooxyderivatives of eyclooxygenase-2 inhibitors
AU2003261319A8 (en)	2004-02-23	Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme
IL153937A0 (en)	2003-07-31	Pharmaceutical combination of angiotensin ii antagonists and angiotensin i converting enzyme inhibitors
AU2003217916A8 (en)	2003-09-22	Stable formulations of angiotensin converting enzyme (ace) inhibitors
AU2003300692A1 (en)	2005-05-19	Stable formulations of ace inhibitors and methods for preparation thereof
AU2003237983A1 (en)	2003-12-22	Derivatives of azepine and thiazeran as interleukin converting enzyme inhibitors
AU2003290417A8 (en)	2004-10-18	Process for the preparation of angiotensin converting enzyme (ace) inhibitors and its use
EP1352911A4 (en)	2007-11-28	Angiotensin converting enzyme inhibitors
AU2003237981A1 (en)	2003-12-22	NOVEL INTERLEUKIN-1Beta CONVERTING ENZYME INHIBITORS
AU2003304374A8 (en)	2005-02-14	Peptide inhibitors of beta-lactamases
AU2003249320A8 (en)	2004-02-09	Novel inhibitors of ubiquitin isopeptidases
AU2003224874A1 (en)	2003-10-27	INHIBITORS OF SERINE AND METALLO-ss-LACTAMASES
PL366419A1 (en)	2005-01-24	Pharmaceutical combination of angiotensin ii antagonists and angiotensin i converting enzyme inhibitors
AU2002950185A0 (en)	2002-09-12	Enzyme inhibitors
AU2003237157A1 (en)	2003-11-17	Preparation of phosphatase inhibitors
GB0109278D0 (en)	2001-05-30	Enzyme inhibitors
AU2002308287A1 (en)	2003-09-09	Pharmaceutical combination of angiotensin ii antagonists and angiotensin i converting enzyme inhibitors
AU2002219620A1 (en)	2002-07-24	Angiotensin converting enzyme inhibitors

Legal Events

Date	Code	Title	Description
2004-11-25	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase